Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1991 3
1992 3
1993 1
1994 3
1996 2
1997 1
2000 2
2003 1
2004 4
2005 2
2007 2
2009 1
2011 2
2012 1
2013 4
2014 6
2015 2
2017 4
2018 1
2019 1
2020 4
2021 2
2022 6
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial.
Juraska M, Early AM, Li L, Schaffner SF, Lievens M, Khorgade A, Simpkins B, Hejazi NS, Benkeser D, Wang Q, Mercer LD, Adjei S, Agbenyega T, Anderson S, Ansong D, Bii DK, Buabeng PBY, English S, Fitzgerald N, Grimsby J, Kariuki SK, Otieno K, Roman F, Samuels AM, Westercamp N, Ockenhouse CF, Ofori-Anyinam O, Lee CK, MacInnis BL, Wirth DF, Gilbert PB, Neafsey DE. Juraska M, et al. Among authors: mercer ld. Lancet Infect Dis. 2024 Sep;24(9):1025-1036. doi: 10.1016/S1473-3099(24)00179-8. Epub 2024 May 6. Lancet Infect Dis. 2024. PMID: 38723650 Free PMC article. Clinical Trial.
Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy.
Juraska M, Early AM, Li L, Schaffner SF, Lievens M, Khorgade A, Simpkins B, Hejazi NS, Benkeser DA, Wang Q, Mercer LD, Adjei S, Agbenyega T, Anderson S, Ansong D, Bii DK, Buabeng PBY, English S, Fitzgerald N, Grimsby J, Kariuki SK, Otieno K, Roman F, Samuels AM, Westercamp N, Ockenhouse CF, Ofori-Anyinam O, Lee CK, MacInnis BL, Wirth DF, Gilbert PB, Neafsey DE. Juraska M, et al. Among authors: mercer ld. medRxiv [Preprint]. 2023 Nov 23:2023.11.22.23298907. doi: 10.1101/2023.11.22.23298907. medRxiv. 2023. PMID: 38045387 Free PMC article. Preprint.
Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial.
Oron AP, Burstein R, Mercer LD, Arzika AM, Kalua K, Mrango Z, West SK, Bailey RL, Porco TC, Lietman TM. Oron AP, et al. Among authors: mercer ld. Am J Trop Med Hyg. 2020 Sep;103(3):1295-1300. doi: 10.4269/ajtmh.18-1004. Am J Trop Med Hyg. 2020. PMID: 30734696 Free PMC article.
Assessing the sensitivity of the polio environmental surveillance system.
Kroiss SJ, Ahmadzai M, Ahmed J, Alam MM, Chabot-Couture G, Famulare M, Mahamud A, McCarthy KA, Mercer LD, Muhammad S, Safdar RM, Sharif S, Shaukat S, Shukla H, Lyons H. Kroiss SJ, et al. Among authors: mercer ld. PLoS One. 2018 Dec 28;13(12):e0208336. doi: 10.1371/journal.pone.0208336. eCollection 2018. PLoS One. 2018. PMID: 30592720 Free PMC article.
Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition.
Rennert W, Hindiyeh M, Allahham M, Mercer LD, Hamad KI, Ghuneim NI, A M Eljaro Z, Abu-Awwad F, Bozya Y, Hjaija D, Bhat N, Leader T, Ramlawi A, Marzouqa H. Rennert W, et al. Among authors: mercer ld. Vaccine. 2023 Jan 23;41(4):945-954. doi: 10.1016/j.vaccine.2022.12.046. Epub 2022 Dec 28. Vaccine. 2023. PMID: 36585280 Free PMC article.
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study.
Erdem R, De Coster I, Withanage K, Mercer LD, Marchant A, Taton M, Cools N, Lion E, Cassels F, Higgins D, Ivinson K, Locke E, Mahmood K, Wright PF, Gast C, White JA, Ackerman ME, Konopka-Anstadt JL, Mainou BA, Van Damme P. Erdem R, et al. Among authors: mercer ld. Vaccine. 2023 Mar 3;41(10):1657-1667. doi: 10.1016/j.vaccine.2023.01.048. Epub 2023 Feb 4. Vaccine. 2023. PMID: 36746739 Free PMC article. Clinical Trial.
Feature-level analysis of a novel smartphone application for smoking cessation.
Heffner JL, Vilardaga R, Mercer LD, Kientz JA, Bricker JB. Heffner JL, et al. Among authors: mercer ld. Am J Drug Alcohol Abuse. 2015 Jan;41(1):68-73. doi: 10.3109/00952990.2014.977486. Epub 2014 Nov 14. Am J Drug Alcohol Abuse. 2015. PMID: 25397860 Free PMC article. Clinical Trial.
62 results